An interventional study of Permethrin Lotion 5% and Permethrin Lotion 5% and Oral Ivermectin 200 mcg/kg in Scabies, sponsored by B.P. Koirala Institute of Health Sciences. Completed. Open to participants aged 5 Years to 80 Years. Per ClinicalTrials.gov, last updated 2022-01-20.
Sponsored by B.P. Koirala Institute of Health Sciences · Not applicable, Interventional, and Treatment
Scabies is associated with significant discomfort and social taboo. Existing treatment regimen frequently fails due to lack of patient compliance. We compared single use regimen to existing standard repeat application regimen for treatment of scabies.
49 studies on the registry are indexed under Scabies; 10 are open to participants now.
This study's enrollment of 212 is above the median of 183 across 41 interventional studies indexed under Scabies.
Browse Scabies studies →B.P. Koirala Institute of Health Sciences is the lead sponsor of 54 studies on the registry; 6 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Standard regimen of permethrin 5% topical application to be repeated after 1 week.
Drug: Permethrin Lotion 5%
A combination regimen of permethrin 5% topical application with oral ivermectin 200 mcg/kg given on the single day only
Drug: Permethrin Lotion 5% and Oral Ivermectin 200 mcg/kg
Topical permethrin 5% lotion to apply on day 1 and repeat after 1 week.
Topical permethrin 5% lotion and oral ivermectin 200 mcg/kg to be taken on day 1 only.
Pruritus
Rate of relief from pruritus assessed using visual analog scale
Time frame: 1 month
Skin lesions
Rate of eradication of skin lesions assessed using physician global assessment scale
Time frame: 1 month
No study locations are listed for this record.
Plan to share: No
This study is completed, as verified in Jan 2022. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
B.P. Koirala Institute of Health Sciences